Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Share News (SPH)

  • There is currently no data for SPH

TechMARK movers: Restructuring costs hit Sinclair figures

Thu, 25th Feb 2010 14:36
Sinclair Pharma shares fell after it reported a slump into loss in 2009 but much of that was due to restructuring costs. However, another large loss is expected this year. New chief executive Chris Spooner has wasted little time in restructuring the business and boosting the sales expertise in the group. He ended Sinclair's distribution agreement with Orapharma Inc for Decapinol mouth rinse and plans to find another partner covering more of the market.Sinclair has negotiated new debt facilities of £9m and raised £18.2m from a share placing. The cash was used to finance the acquisition of Flammazine and Flammacerium (used for topical treatment of burns) from Solvay Pharmaceuticals for £16.8m. Sinclair had net debt of £12.3m at the end of 2009.Revenues were one-third lower than last year at £11m. Stripping out one-off payments, underlying revenues were 1% lower. Sinclair made a profit of £3.17m in 2008 but that was down to foreign exchange gains. The 2009 loss was £14.5m and around two-thirds of this was due to impairment charges and restructuring costs. Broker Singer has increased its forecast loss for 2010 from £6.1m to £15m. Stripping out exceptional charges the forecast loss rises from £1.7m to £2m. Singer has a 41p a share price target and says it believes that "the company is now better placed to deliver long term financial growth". Shares in IT services provider Logica are recovering following yesterday's fall on the announcement of figures for 2009. Revenues are expected to fall in the first half of 2010 and be flat for the year as a whole. FTSE TechMARK - RisersVisonic (VSC) 82.00p +2.50%Psion (PON) 92.00p +2.22%Ark Therapeutics (AKT) 14.50p +1.75%NXT (NTX) 14.75p +1.72%BT Group (BT.A) 117.60p +1.29%Intec Telecom Systems (ITL) 98.00p +1.29%COLT Telecom Group S.A. (COLT) 136.50p +1.11%Logica (LOG) 118.20p +1.11%Vodafone Group (VOD) 142.20p +0.85%Anite Group (AIE) 32.50p +0.78%FTSE TechMARK - FallersRenovo Group (RNVO) 27.25p -6.03%Sinclair Pharma (SPH) 29.50p -4.84%Oxford Instruments (OXIG) 232.00p -4.13%Gresham Computing (GHT) 19.00p -3.80%Vernalis (VER) 73.50p -3.61%Morse (MOR) 40.00p -2.44%Phoenix IT Group (PNX) 275.00p -2.22%Innovation Group (TIG) 12.50p -1.96%XP Power (XPP) 425.00p -1.96%Consort Medical (CSRT) 356.00p -1.79%

Related News

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)
23 Oct 2018

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Tuesday that GLG Partners LP doubled its stake in the company to 10.81%.GLG's previous holding in th...

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)
19 Oct 2018

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Friday that Toscafund Asset Management LLP divested its entire stake in the company.Prior to selling...

Sinclair Pharma News

Sinclair IS Pharma squeezes losses
22 Sep 2011

Sinclair IS Pharma squeezes losses

Skin treatments supplier Sinclair IS Pharma said recent trading has been 'particularly encouraging' and is confident that the momentum will build thro...

UPDATE: Tuesday broker round-up
20 Sep 2011

UPDATE: Tuesday broker round-up

BAE Systems: Societe Generale upgrades to buy, raises target to 330p from 280p. Kesa Electricals: Espirito Santo downgrades to sell, cuts target from...

Sinclair IS signs agreement with Teva
31 Aug 2011

Sinclair IS signs agreement with Teva

Sinclair IS Pharma has signed a license agreement with Teva Pharmaceutical Industries for Sinclair's oncology supportive care product, known as 'episi...

Sinclair sees revenue ahead of expectations
14 Jul 2011

Sinclair sees revenue ahead of expectations

Skin treatments supplier Sinclair IS Pharma said full year revenue raced ahead of expectations last year due to a strong performance in its fourth qua...

Sinclair Pharma CFO heads for the door
10 Jun 2011

Sinclair Pharma CFO heads for the door

Skin treatments supplier Sinclair Pharma announced the departure of chief financial officer Matthew Hall with immediate effect. Hall worked at IS Ph...

JD Wetherspoon chief exec share sale nets £90,000
4 May 2011

JD Wetherspoon chief exec share sale nets £90,000

JD Wetherspoon's chief executive John Hutson pocketed has pocketed more than £90,000 from the sale of shares in the pub chain operator. He offloaded ...

Sinclair non-exec takes more shares
3 May 2011

Sinclair non-exec takes more shares

Jean-Charles Tschudin, a non-executive director at the skin care products supplier Sinclair Pharma, has added to his holding in the company with the p...

London close: Shares in late dive
7 Apr 2011

London close: Shares in late dive

Shares were little changed for much of the day as central banks in London and Frankfurt acted as expected, but another earthquake in Japan sent jitter...